Arkolith/Insider Trading/TBIO/Form 4

Burgess Paul D.

Chief Operating Officer, CLOTranslate Bio, Inc. (TBIO) · full profile →Form 4 · filed Sep 14, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.7M
Net Open-Market Flow
-$2.7M
Transactions
6
1 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 14, 2021Sell(S)72K$38.00$2.7M0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Sep 14, 2021Sell(S)220K—$00
Sep 14, 2021Sell(S)70K—$00
Sep 14, 2021Sell(S)150K—$00
Sep 14, 2021Sell(S)90K—$00
Sep 14, 2021Sell(S)150K—$00

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-056057) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML